(202) 688 0222
CME Coalition
  • Home
  • About
    • Members
    • Staff
    • FAQ
  • Membership
    • What We Do
    • Prospectus
    • Join the Coalition
  • Issues
    • The Value of CME
    • COVID-19
    • Health Disparities
    • Quality Improvement CME
    • Shared Decision-Making
    • Open Payments
    • CME vs. Marketing
  • Resources
    • CME in the News
    • Code of Conduct
    • Commercial Logo Use
    • MACRA
    • Press Releases
    • Privacy Policies
    • REMS
    • Sunshine Act
    • Webinars
  • Contact

CME Coalition Submits Comments on Cures 2.0

12/17/2019

 
The CME Coalition has submitted comments to Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) in response to their solicitation for comments on ‘Cures 2.0’ — an important next step in their efforts to advance medical research and foster innovation.  As the letter points out, policymakers have increasingly recognized that there is an important role for enhanced provider education to address discrete policy challenges.

Read More

Continuing Medical Education (CME) Legislation in the 115th Congress

5/7/2018

 
As part of the Coalition’s ongoing monitoring and analysis of legislative opportunities related to CME, the Coalition has reviewed all relevant legislation that has been introduced in the 115th Congress and generated a new document outlining specific bills that prioritize the essential role of CME in improving health outcomes

Read More

VIDEO: CME AND THE FIGHT AGAINST OPIOID ABUSE

5/26/2017

 
​Nearly 100 million people in the United States, or roughly one-third of the population, experience some form of chronic pain. Meanwhile, prescription opiate abuse and addiction have reached epidemic proportions in the United States, including the widespread illegal diversion of prescription opioids for street use, which in turn can increase the rates of abuse of illegal narcotics. Some clinicians have also prescribed opioids without adequate training surrounding their abuse potential. Many primary-care providers have recently become reluctant to prescribe opioid pain relievers in the context of current public health concerns surrounding addiction, which leads to some chronic pain patients now going without any appropriate treatment. 

Read More

CME Coalition Discusses Importance of Prescriber Education at FDA Workshop

5/10/2017

 
On May 3 and 4, 2017, the Food and Drug Administration (FDA) convened a public workshop (agenda) examining “Training Health Care Providers on Pain Management and Safe Use of Opioid Analgesics.” Andy Rosenberg presented testimony on behalf of the CME Coalition, in which he spoke to the role of CME in opioid prescriber education. Among the key points made in Andy’s remarks, "FDA should continue to rely on accredited CME as a vital tool in prescriber education in the opioid space. The strength of CME is that it can produce myriad educational activities that are targeted to physicians based on their professional practice gaps, individualized needs, and stages of learning and change. Added flexibility will allow prescriber education to better address individual prescribers’ educational and practice needs... Finally, as an incentive for prescribers to participate in opioid REMS, we recommend that the FDA encourage CMS to include opioid REMS as an improvement activity in the Quality Payment Program MIPS.”

Read More

CME Submits Public Comments on FDA Opioid REMS

6/3/2016

 
On May 3-4, 2016, the Food and Drug Administration (FDA) hosted a two-day long Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to discuss results from assessments of the extended-release and long-acting (ER/LA) Opioid Analgesics REMS.  The CME Coalition submitted public comments following the meeting, emphasizing that ​FDA should consider standardizing the REMS process, while allowing more flexibility in content. The Coalition also suggested that REMS should be expanded to include short acting opioids. 

Read More
<<Previous

About

Mission
Government Affairs
Issues
Members
Staff
FAQ

Membership

Why Join
Testimonials
Join the Coalition

Resources

Sunshine Act
REMS
Commercial Logo Use
Privacy Policies
Code of Conduct

Newsroom

Press Releases
CME in the News
Blog
Picture
Copyright © 2014 CME Coalition | 1720 Eye St. NW, Washington DC | clamond@thornrun.com